Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iovance Biotherapeutics Inc (IOVA)

Iovance Biotherapeutics Inc (IOVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,669,138
  • Shares Outstanding, K 123,514
  • Annual Sales, $ 0 K
  • Annual Income, $ -123,580 K
  • 60-Month Beta 1.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 6.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.29
  • Number of Estimates 8
  • High Estimate -0.18
  • Low Estimate -0.34
  • Prior Year -0.34
  • Growth Rate Est. (year over year) +14.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.05 +34.64%
on 05/22/19
23.26 -7.09%
on 06/20/19
+5.41 (+33.40%)
since 05/21/19
3-Month
9.21 +134.64%
on 03/25/19
23.26 -7.09%
on 06/20/19
+11.30 (+109.60%)
since 03/21/19
52-Week
7.26 +197.66%
on 12/21/18
23.26 -7.09%
on 06/20/19
+8.46 (+64.33%)
since 06/21/18

Most Recent Stories

More News
Cancer-Fighting Stocks & ETF: What You Need to Know

Many biotech stocks soared after they presented very promising cancer treatment results at the ASCO conference

IOVA : 21.61 (-3.57%)
AZN : 41.36 (-0.60%)
CNCR : 20.98 (+0.21%)
MRK : 84.57 (-0.04%)
CHNA : 22.06 (-2.43%)
BMY : 49.34 (+0.92%)
NKTR : 34.86 (-1.50%)
Why Cancer-Fighting Stocks & ETFs Are Soaring

The cancer immunotherapy ETF is soaring today as some of its holdings presented very promising results at the ASCO conference. Find out more on the podcast.

CELG : 98.91 (+0.79%)
IOVA : 21.61 (-3.57%)
AZN : 41.36 (-0.60%)
CNCR : 20.98 (+0.21%)
MRK : 84.57 (-0.04%)
CHNA : 22.06 (-2.43%)
LLY : 115.49 (-0.06%)
MRTX : 101.44 (-1.28%)
BMY : 49.34 (+0.92%)
NKTR : 34.86 (-1.50%)
Iovance Biotherapeutics Announces New Facility to Support U.S. Production of Tumor Infiltrating Lymphocyte Cell Therapy Products

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it...

IOVA : 21.61 (-3.57%)
JLL : 139.55 (-0.81%)
Implied Volatility Surging for Iovance Biotherapeutics (IOVA) Stock Options

Investors need to pay close attention to Iovance Biotherapeutics (IOVA) stock based on the movements in the options market lately.

IOVA : 21.61 (-3.57%)
First Week of July 19th Options Trading For Iovance Biotherapeutics (IOVA)

Investors in Iovance Biotherapeutics Inc saw new options begin trading this week, for the July 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IOVA options...

IOVA : 21.61 (-3.57%)
Thinking about buying stock in Aurora Cannabis, Applied Materials, Iovance Biotherapeutics, NVIDIA, or Under Armour?

InvestorsObserver issues critical PriceWatch Alerts for ACB, AMAT, IOVA, NVDA, and UAA.

AMAT : 42.96 (-0.58%)
NVDA : 151.76 (-1.52%)
ACBFF : 8.6900 (-12.80%)
IOVA : 21.61 (-3.57%)
UAA : 26.15 (-1.62%)
Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs

Patients with advanced cervical cancer treated with LN-145 had an objective response rate of 44 percent

IOVA : 21.61 (-3.57%)
Iovance Biotherapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update

- First patient dosed in pivotal Cohort 4 in study of lifileucel in advanced melanoma; regulatory submission planned for late 2020 -

IOVA : 21.61 (-3.57%)
Iovance Biotherapeutics to Participate in Upcoming Conferences in May

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the...

IOVA : 21.61 (-3.57%)
Iovance Biotherapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on Tuesday, May 7, 2019

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it...

IOVA : 21.61 (-3.57%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade IOVA with:

Business Summary

Iovance Biotherapeutics, Inc. is a biopharmaceutical company. It focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. Iovance Biotherapeutics Inc., formerly known as Lion Biotechnologies...

See More

Key Turning Points

2nd Resistance Point 23.09
1st Resistance Point 22.35
Last Price 21.61
1st Support Level 20.75
2nd Support Level 19.89

See More

52-Week High 23.26
Last Price 21.61
Fibonacci 61.8% 17.15
Fibonacci 50% 15.26
Fibonacci 38.2% 13.37
52-Week Low 7.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar